AABB hosts biannual meetings that bring together representatives from the blood community with FDA and other relevant federal government agencies to exchange information on topics of mutual concern. Click on a meeting date below for summaries, attendance lists and other resources.
FDA Liaison Meeting - 5/16/19
FDA Liaison Meeting - 3/6/18
FDA Liaison Meeting - 1/31/17
FDA Liaison Meeting - 5/9/16
FDA Liaison Meeting - 9/21/15
FDA Liaison Meeting - 2/27/15
FDA Liaison Meeting - 5/16/14
FDA Liaison Meeting - 9/27/13
FDA Liaison Meeting - 5/2/13
FDA Liaison Meeting - 11/1/12
FDA Liaison Meeting - 4/12/12
FDA Liaison Meeting - 9/30/11
FDA Liaison Meeting - 3/30/11
FDA Liaison Meeting - 11/23/10
FDA Liaison Meeting - 1/7/10
REGULATORY UPDATE: ‘Ask the FDA and CMS/CLIA 2024’ Annual Meeting Slides Now Available
November 20, 2024
REGULATORY UPDATE: FDA Issues Draft Guidance to Support CGT Development
November 19, 2024
FDA Approves Direct-to-Brain Gene Therapy for AADC Deficiency
November 14, 2024